Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fluorescence Imaging Analysis of PTK7 Clustering in Situ via a Programmable DNA Network for Apoptosis Induction and Drug Resistance Reversal. | Anal Chem | 2026 | 41949051 | PubTator, text mining | PubMed |
| Extracellular payload release from non-internalizing antibody-drug conjugates: mechanisms and linker technologies. | Drug Deliv | 2026 | 41866709 | PubTator, text mining | PubMed |
| Beyond CAR-T and oncology: broadening chimeric antigen receptor technologies across cell types and diseases. | Precis Clin Med | 2026 | 41836149 | PubTator, text mining | PubMed |
| Synthetic aptamer mechanoreceptors enable cell-specific force sensing and temporal control via DNA circuits. | Nat Commun | 2026 | 41833970 | PubTator, text mining | PubMed |
| Aptamer-Mediated Proximity Labeling (ApMPL) for Spatially Resolved Deciphering of Cell Membrane Protein Interactomes. | Anal Chem | 2026 | 41786503 | PubTator, text mining | PubMed |
| Spatiotemporal Organization of PTK7 Diffusion on Cell Surface Facilitates Tumor Invasion and Migration. | Adv Sci (Weinh) | 2026 | 41782379 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. | Front Bioeng Biotechnol | 2026 | 41768137 | PubTator, text mining | PubMed |
| Reversing Mitochondrial Dysfunction in Optineurin E50K Glaucoma: A Metabolic Approach to Neuroprotection. | Res Sq | 2026 | 41756461 | PubTator, text mining | PubMed |
| Tetralogy of Fallot: Genetic, Epigenetic and Clinical Insights into a Multifactorial Congenital Heart Disease. | Genes (Basel) | 2026 | 41751564 | PubTator, text mining | PubMed |
| Unlocking the "undruggable": current landscape and emerging frontiers in lysosomal receptor-mediated protein degradation. | Drug Deliv | 2026 | 41742445 | PubTator, text mining | PubMed |
| INHBA: a mitochondrial-related pan-cell death gene associated with the prognosis and immunity of OSCC. | Sci Rep | 2026 | 41741523 | PubTator, text mining | PubMed |
| Exosome Augmentation Technologies for Drug Delivery and Disease Treatment: A Review. | Biomater Res | 2026 | 41728072 | PubTator, text mining | PubMed |
| Genetics of CAKUT. | Med Genet | 2026 | 41710414 | PubTator, text mining | PubMed |
| Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. | J Immunother Cancer | 2026 | 41629132 | PubTator, text mining | PubMed |
| Utility of a Digital PCR-Based Gene Expression Panel for Detection of Leukemic Cells in Pediatric Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2026 | 41596324 | PubTator, text mining | PubMed |
| RoboA reinforces planarian stem cell fate through FoxA and Anosmin1a. | Nat Commun | 2026 | 41577713 | PubTator, text mining | PubMed |
| Proteomic Signatures of Cardiac Dysfunction Among People With Diabetes: The Atherosclerosis Risk in Communities Study. | Circ Heart Fail | 2026 | 41569286 | PubTator, text mining | PubMed |
| Targeting SPAK suppresses progression and averts an immune exhaustive microenvironment in hepatocellular carcinoma. | Nat Commun | 2026 | 41526378 | PubTator, text mining | PubMed |
| Interplay between extracellular matrix mechanics and cell function in mechanobiology. | Curr Opin Biomed Eng | 2025 | 42006117 | PubTator, text mining | PubMed |
| Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome. | Int J Mol Sci | 2025 | 41516322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=2